The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
MHC class I antigens, immune surveillance, and tumor immune escape
Abstract
Oncogenic transformation in human and experimental animals is not necessarily followed by the appearance of a tumor mass. The immune system of the host can recognize tumor antigens by the presentation of small antigenic peptides to the receptor of cytotoxic T‐lymphocytes (CTLs) and reject the nascent tumor. However, cancer cells can sometimes escape these specific T‐cell immune responses in the course of somatic (genetic and phenotypic) clonal evolution. Among the tumor immune escape mechanisms described to date, the alterations in the expression of major histocompatibility complex (MHC) molecules play a crucial step in tumor development due to the role of MHC antigens in antigen presentation to T‐lymphocytes and the regulation of natural killer cell (NK) cell function. In this work, we have (1) updated information on the mechanisms that allow CTLs to recognize tumor antigens after antigen processing by transformed cells, (2) described the altered MHC class I phenotypes that are commonly found in human tumors, (3) summarized the molecular mechanisms responsible for MHC class I alteration in human tumors, (4) provided evidence that these altered human leukocyte antigens (HLA) class I phenotypes are detectable as result of a T‐cell immunoselection of HLA class I‐deficient variants by an immunecompetent host, and (5) presented data indicating the MHC class I phenotype and the immunogenicity of experimental metastatic tumors change drastically when tumors develop in immunodeficient mice. © 2003 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure of the human class I histocompatibility antigen, HLA-A2
Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennett, W. S., Strominger, J. L., & Wiley, D. C. (1987) · Nature · doi:10.1038/329506a0 · Cited by 3,472
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896
In search of the ‘missing self’: MHC molecules and NK cell recognition
Ljunggren, H.-G., & Kärre, K. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90097-s · Cited by 2,687
Townsend, A. (1986) · Cell · doi:10.1016/0092-8674(86)90019-x · Cited by 1,699
The Concept of Immunological Surveillance
Burnet, F. M. (2015) · Progress in Tumor Research · doi:10.1159/000386035 · Cited by 1,656
Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., & Schreiber, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7556 · Cited by 1,465
Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
Hahne, M., Rimoldi, D., Schröter, M., Romero, P., Schreier, M., French, L. E., Schneider, P., Bornand, T., Fontana, A., Lienard, D., et al. (1996) · Science · doi:10.1126/science.274.5291.1363 · Cited by 1,249
Tumor Antigens Recognized by T Lymphocytes
Boon, T., Cerottini, J.-C., Van den Eynde, B., van der Bruggen, P., & Van Pel, A. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.002005 · Cited by 1,221
Marincola, F. M., Jaffee, E. M., Hicklin, D. J., & Ferrone, S. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60911-6 · Cited by 1,174
MECHANISMS OF MHC CLASS I–RESTRICTED ANTIGEN PROCESSING
Pamer, E., & Cresswell, P. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.323 · Cited by 1,008
RECEPTORS FOR HLA CLASS-I MOLECULES IN HUMAN NATURAL KILLER CELLS
Moretta, A., Bottino, C., Vitale, M., Pende, D., Biassoni, R., Mingari, M. C., & Moretta, L. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.619 · Cited by 875
Implications for immunosurveillance of altered HLA class I phenotypes in human tumours
Garrido, F., Ruiz-Cabello, F., Cabrera, T., Pérez-Villar, J. J., López-Botet, M., Duggan-Keen, M., & Stern, P. L. (1997) · Immunology Today · doi:10.1016/s0167-5699(96)10075-x · Cited by 770
Self-citationIkeda, H., Lethé, B., Lehmann, F., Van Baren, N., Baurain, J.-F., De Smet, C., Chambost, H., Vitale, M., Moretta, A., Boon, T., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80426-4 · Cited by 762
Klein, G., Sjögren, H. O., Klein, E., & Hellström, K. E. (1960) · PubMed · Cited by 742
STRUCTURE, FUNCTION, AND DIVERSITY OF CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULES
Bjorkman, P. J., & Parham, P. (1990) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.59.070190.001345 · Cited by 700 · cited 2×
“C and the H-2K, D, and L HCs are highly polymorphic (Bjorkman and Parham, 1990).”
BackgroundPopulation Biology of Antigen Presentation by MHC Class I Molecules
Parham, P., & Ohta, T. (1996) · Science · doi:10.1126/science.272.5258.67 · Cited by 655
Identification of human cancers deficient in antigen processing.
Restifo, N. P., Esquivel, F., Kawakami, Y., Yewdell, J. W., Mulé, J. J., Rosenberg, S. A., & Bennink, J. R. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.2.265 · Cited by 624
Antigen-processing machinery breakdown and tumor growth
Seliger, B., Maeurer, M. J., & Ferrone, S. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01692-3 · Cited by 459
Immune surveillance against a solid tumor fails because of immunological ignorance
Ochsenbein, A. F., Klenerman, P., Karrer, U., Ludewig, B., Pericin, M., Hengartner, H., & Zinkernagel, R. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2233 · Cited by 453
Natural history of HLA expression during tumour development
Garrido, F., Cabrera, T., Concha, A., Glew, S., Ruiz-Cabello, F., & Stern, P. L. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90264-l · Cited by 448
Self-citationTHE DETAILED DISTRIBUTION OF HLA-A, B, C ANTIGENS IN NORMAL HUMAN ORGANS
DAAR, A. S., FUGGLE, S. V., FABRE, J. W., TING, A., & MORRIS, P. J. (1984) · Transplantation · doi:10.1097/00007890-198409000-00018 · Cited by 406
HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story
Hicklin, D. J., Marincola, F. M., & Ferrone, S. (1999) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01451-3 · Cited by 376
The host—tumor immune conflict: from immunosuppression to resistance and destruction
Chouaib, S., Asselin-Paturel, C., Mami-Chouaib, F., Caignard, A., & Blay, J. Y. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01115-8 · Cited by 350
Cromme, F. V., Airey, J., Heemels, M. T., Ploegh, H. L., Keating, P. J., Stern, P. L., Meijer, C. J., & Walboomers, J. M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.1.335 · Cited by 330
Genetic and Functional Relationships between MHC and NK Receptor Genes
Trowsdale, J. (2001) · Immunity · doi:10.1016/s1074-7613(01)00197-2 · Cited by 321
D'Urso, C. M., Wang, Z. G., Cao, Y., Tatake, R., Zeff, R. A., & Ferrone, S. (1991) · Journal of Clinical Investigation · doi:10.1172/jci114984 · Cited by 309
MHC antigens and tumor escape from immune surveillance
(2001) · Advances in Cancer Research · doi:10.1016/s0065-230x(01)83005-0 · Cited by 305
Selection, the mutation rate and cancer: Ensuring that the tail does not wag the dog
Tomlinson, I., & Bodmer, W. (1999) · Nature Medicine · doi:10.1038/4687 · Cited by 296
Koopman, L. A., Corver, W. E., van der Slik, A. R., Giphart, M. J., & Fleuren, G. J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.6.961 · Cited by 279
HLA class I antigen abnormalities and immune escape by malignant cells
Seliger, B., Cabrera, T., Garrido, F., & Ferrone, S. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0404 · Cited by 270
Self-citationSerrano, A., Tanzarella, S., Lionello, I., Mendez, R., Traversari, C., Ruiz-Cabello, F., & Garrido, F. (2001) · International Journal of Cancer · doi:10.1002/ijc.1452 · Cited by 239
Self-citationMolecular Characterization of Defective Antigen Processing in Human Prostate Cancer
Sanda, M. G., Restifo, N. P., Walsh, J. C., Kawakami, Y., Nelson, W. G., Pardoll, D. M., & Simons, J. W. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.4.280 · Cited by 235
Lehmann, F., Marchand, M., Hainaut, P., Pouillart, P., Sastre, X., Ikeda, H., Boon, T., & Coulie, P. G. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250206 · Cited by 225
Functions of nonclassical MHC and non-MHC-encoded class I molecules
Braud, V. M., Allan, D. S., & McMichael, A. J. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)80018-1 · Cited by 217
IGF-I and IGF-II in relation to colorectal cancer
Manousos, O. N., Souglakos, J., Bosetti, C., Τζώνου, Α., Chatzidakis, V., Trichopoulos, D., Adami, H., & Mantzoros, C. S. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990924)83:1<91::aid-ijc17>3.0.co;2-4 · Cited by 190
NK cell recognition of non-classical HLA class I molecules
López-Botet, Llano, M., Navarro, F., & Bellon, T. (2000) · Seminars in Immunology · doi:10.1006/smim.2000.0213 · Cited by 179
Analysis of HLA-E expression in human tumors
Marín, R., Ruiz-Cabello, F., Pedrinaci, S., Méndez, R., Jiménez, P., Geraghty, D. E., & Garrido, F. (2003) · Immunogenetics · doi:10.1007/s00251-002-0526-9 · Cited by 178
Self-citationHigh frequency of altered HLA class I phenotypes in invasive colorectal carcinomas
Cabrera, T., Collado, A., Fernandez, M. A., Ferron, A., Sancho, J., Ruiz‐Cabello, F., & Garrido, F. (1998) · Tissue Antigens · doi:10.1111/j.1399-0039.1998.tb02274.x · Cited by 175
Self-citationJohnsen, A. K., Templeton, D. J., Sy, M.-S., & Harding, C. V. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.8.4224 · Cited by 173
Garrido, F., FESTENSTEIN, H., & Schirrmacher, V. (1976) · Nature · doi:10.1038/261705a0 · Cited by 149
Self-citationBenitez, R., Godelaine, D., López‐Nevot, M. Á., Brasseur, F., Jimenez, P., Marchand, M.-C., Oliva, M. R., van Baren, N., Cabrera, T., Andry, G., et al. (1998) · Tissue Antigens · doi:10.1111/j.1399-0039.1998.tb03082.x · Cited by 149
Self-citationFunction of the transport complex TAP in cellular immune recognition
Abele, R., & Tampé, R. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00171-6 · Cited by 134
HLA Class I Chromosomal Region, Genes, and Products: Facts and Questions
Bouteiller, P. P. L. (2017) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v37.i2-6.80 · Cited by 131
HLA Class I Chromosomal Region, Genes, and Products: Facts and Questions
Bouteiller, P. P. L. (1994) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v14.i2.10 · Cited by 130
Multiple mechanisms underlie HLA dysregulation in cervical cancer
Brady, C. S., Bartholomew, J. S., Burt, D. J., Duggan-Keen, M. F., Glenville, S., Telford, N., Little, A., Davidson, J. A., Jiménez, P., Ruiz‐Cabello, F., et al. (2000) · Tissue Antigens · doi:10.1034/j.1399-0039.2000.550502.x · Cited by 128
Self-citationHigh frequency of altered HLA class I phenotypes in invasive breast carcinomas
Cabrera, T., Fernandez, M. A., Sierra, À., Garrido, A., Herruzo, A., Escobedo, A., Fabra, À., & Garrido, F. (1996) · Human Immunology · doi:10.1016/0198-8859(96)00145-0 · Cited by 126
Self-citationTumour immunology: MHC antigens and malignancy
FESTENSTEIN, H., & Garrido, F. (1986) · Nature · doi:10.1038/322502a0 · Cited by 121
Self-citationAnalysis of HLA expression in human tumor tissues
Cabrera, T., López‐Nevot, M. Á., Gaforio, J. J., Ruiz‐Cabello, F., & Garrido, F. (2003) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-002-0332-0 · Cited by 119
Self-citationRitz, U., Momburg, F., Pilch, H., Huber, C. G., Maeurer, M. J., & Seliger, B. (2001) · International Journal of Oncology · doi:10.3892/ijo.19.6.1211 · Cited by 111
Maleno, I., López‐Nevot, M. Á., Cabrera, T., Jose, S., & Garrido, F. (2002) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-002-0296-0 · Cited by 111
Self-citationTapasin: an ER chaperone that controls MHC class I assembly with peptide
Grandea, A. G., & Kaer, L. V. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01861-0 · Cited by 102
Wang, Z., Marincola, F. M., Rivoltini, L., Parmiani, G., & Ferrone, S. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.2.205 · Cited by 102
Mechanisms of loss of HLA class I expression on colorectal tumor cells
Browning, M. J., Petronzelli, F., Bicknell, D. C., Krausa, P., Rowan, A., Tonks, S., Murray, N., Bodmer, J. G., & Bodmer, W. F. (1996) · Tissue Antigens · doi:10.1111/j.1399-0039.1996.tb02571.x · Cited by 101
ENGEL, A. ‐., Svane, I. M., Rygaard, J., & Werdelin, O. (1997) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1997.d01-419.x · Cited by 101
Feenstra, M., Veltkamp, M., van Kuik, J., Wiertsema, S. P., Slootweg, P. J., van den Tweel, J. G., de Weger, R. A., & Tilanus, M. G. J. (1999) · Tissue Antigens · doi:10.1034/j.1399-0039.1999.540304.x · Cited by 98
Mareel, M. M. K., Roy, F. M. V., & BAETSELIER, P. D. (1990) · Cancer and Metastasis Reviews · doi:10.1007/bf00047588 · Cited by 95
Garcia-Lora, A. M., Martinez, M., Algarra, I., Gaforio, J. J., & Garrido, F. (2003) · International Journal of Cancer · doi:10.1002/ijc.11241 · Cited by 92
Self-citationLoss of interferon-gamma inducibility of TAP1 and LMP2 in a renal cell carcinoma cell line.
Dovhey, S. E., Ghosh, N., & Wright, K. L. (2000) · PubMed · Cited by 88
Immunoselection by T lymphocytes generates repeated MHC class I-deficient metastatic tumor variants
Garcia-Lora, A. M., Algarra, I., Gaforio, J. J., Ruiz‐Cabello, F., & Garrido, F. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20010101)91:1<109::aid-ijc1017>3.0.co;2-e · Cited by 85
Self-citationLoss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line
Torres, M. J., Ruiz‐Cabello, F., Skoudy, A., Berrozpe, G., Jiménez, P., Serrano, A., Real, F. X., & Garrido, F. (1996) · Tissue Antigens · doi:10.1111/j.1399-0039.1996.tb02572.x · Cited by 83
Self-citationGenes regulating MHC class I processing of antigen
Endert, P. V. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)80015-6 · Cited by 82
Svane, I. M., Engel, A., Nielsen, M.-B., et al. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260827 · Cited by 79
Vitale, M., Zimmer, J., Castriconi, R., Hanau, D., Donato, L., Bottino, C., Moretta, L., de la Salle, H., & Moretta, A. (2002) · Blood · doi:10.1182/blood.v99.5.1723 · Cited by 78
Structural and functional analysis of β2 microglobulin abnormalities in human lung and breast cancer
Chen, H. L., Gabrilovich, D. I., Virmani, A. K., Ratnani, I., Girgis, K. R., Nadaf, S., Fernández-Viña, M., & Carbone, D. P. (1996) · International Journal of Cancer · Cited by 63
Molecular strategies to define HLA haplotype loss in microdissected tumor cells
Ramal, L. M., Maleno, I., Cabrera, T., Collado, A., Ferrón, A., López‐Nevot, M. Á., & Garrido, F. (2000) · Human Immunology · doi:10.1016/s0198-8859(00)00171-3 · Cited by 60
Self-citationLocus-specific transcriptional control of HLA genes
Soong, T. W., & Hui, K. M. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.6.2008 · Cited by 56
Abril, E., Mendez, R. E., Garcia-Lora, A. M., Serrano, A., Cabrera, T., Garrido, F., & Ruiz‐Cabello, F. (1996) · Tissue Antigens · doi:10.1111/j.1399-0039.1996.tb02574.x · Cited by 55
Self-citationProgress in manual breast examination
Hall, D. C., Goldstein, M. K., & Stein, G. H. (1977) · Cancer · doi:10.1002/1097-0142(197707)40:1<36::aid-cncr2820400108>3.0.co;2-7 · Cited by 54
A new β2 microglobulin mutation found in a melanoma tumor cell line
Pérez, B. F., Benitez, R., Fernández, M. A., Oliva, M. R., Soto, J. L., Serrano, S., López‐Nevot, M. Á., & Garrido, F. (1999) · Tissue Antigens · doi:10.1034/j.1399-0039.1999.530607.x · Cited by 49
Self-citationMHC Class I Antigen Processing Pathways
Maffei, A., Papadopoulos, K. P., & Harris, P. E. (1997) · Human Immunology · doi:10.1016/s0198-8859(97)00084-0 · Cited by 49
High frequency of altered HLA class I phenotypes in laryngeal carcinomas
Cabrera, T., Jose, S., Fernandez, M. A., Garrido, A., Esquivias, J., & Garrido, F. (2000) · Human Immunology · doi:10.1016/s0198-8859(00)00097-5 · Cited by 48
Self-citationPérez, M., Algarra, I., Ljunggren, H., Caballero, A., Mialdea, M. J., Gaforio, J. J., Klein, G. O., Kärre, K., & Garrido, F. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910460219 · Cited by 39
Self-citationThe great escape: Is immune evasion required for tumor progression?
Villunger, A., & Strasser, A. (1999) · Nature Medicine · doi:10.1038/11311 · Cited by 38
Peltenburg, L. T. C., & Schrier, P. I. (1994) · Immunogenetics · doi:10.1007/bf00163964 · Cited by 37
Real, L. M., Jimenez, P., Cantón, J., Kirkin, A. F., Garcia-Lora, A. M., Abril, E., Zeuthen, J., Ruiz‐Cabello, F., & Garrido, F. (1998) · International Journal of Cancer · Cited by 36
Self-citationMéndez, R., Serrano, A., Jäger, E., Maleno, I., Ruiz‐Cabello, F., Knuth, A. K., & Garrido, F. (2001) · Tissue Antigens · doi:10.1034/j.1399-0039.2001.057006508.x · Cited by 35
Self-citationSerrano, A., Brady, C. S., Jimenez, P., Duggan-Keen, M. F., Méndez, R., Stern, P. L., Garrido, F., & Ruiz‐Cabello, F. (2000) · Immunogenetics · doi:10.1007/s002510000239 · Cited by 30
Self-citationAlgarra, I., Gaforio, J. J., Garrido, A., Mialdea, M. J., Pérez, M., & Garrido, F. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910470716 · Cited by 30
Self-citationMHC loss in colorectal tumours: evidence for immunoselection?
Kaklamanis, L., & Hill, A. (1992) · PubMed · Cited by 26
MHC CLASS I AND II ANTIGENS ON GASTRIC CARCINOMAS AND AUTOLOGOUS MUCOSA
FERRON, A. D., Perez‐Ayala, M., Concha, Á., Cabrera, T., Redondo, M., Oliva, M. R., Ruiz‐Cabello, F., & Garrido, F. (1989) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.1989.tb00489.x · Cited by 25
Self-citationSelection of metastatic tumour phenotypes by host immune systems
Seymour, K., Pettit, S. J., O'Flaherty, E., Charnley, R., & Kirby, J. A. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04435-9 · Cited by 19
HLA Class I and II Expression in Rhabdomyosarcomas
Fernández, J. E., Concha, Á., Aránega, A., Ruiz‐Cabello, F., Cabrera, T., & Garrido, F. (1991) · Immunobiology · doi:10.1016/s0171-2985(11)80208-1 · Cited by 18
Self-citationRelevance of AIDS treatment with two nucleoside analogues alone
Weidle, P., Mbidde, E. K., Djomand, G., & Lackritz, E. (1999) · The Lancet · doi:10.1016/s0140-6736(99)00161-0 · Cited by 6
Moog-Lutz (1997) · Pure Amsterdam UMC · doi:10.1002/(sici)1097-0215(19970410)71:2
Cited by
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
Dongre, A., & Weinberg, R. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0080-4 · Cited by 3,876
A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer
Morse, M. A., Garst, J., Osada, T., Khan, S., Hobeika, A., Clay, T. M., Valente, N., Shreeniwas, R., Sutton, M. A., Delcayre, A., et al. (2005) · Journal of Translational Medicine · doi:10.1186/1479-5876-3-9 · Cited by 1,120
Present yourself! by MHC class I and MHC class II molecules
Rock, K. L., Reits, E., & Neefjes, J. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.08.010 · Cited by 814
HUMAN T CELL RESPONSES AGAINST MELANOMA
Boon, T., Coulie, P. G., Eynde, B. J. V. D., & Bruggen, P. V. D. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090733 · Cited by 651
Barkal, A. A., Weiskopf, K., Kao, K. S., Gordon, S. R., Rosental, B., Yiu, Y. Y., George, B. M., Markovic, M., Ring, N. G., Tsai, J. M., et al. (2018) · Nature Immunology · doi:10.1038/s41590-017-0004-z · Cited by 558
Metadata
- Authors
- Garcia‐Lora, A., Algarra, I., & Garrido, F.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2003-04-09
- Volume
- 195
- Issue
- 3
- Pages
- 346-355
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2095224412
- Cited by
- 501
- References
- 84
- FWCI
- 7.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.